Zydus Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The entire Zydus promoter group, comprising 31+ entities and individuals including Pankaj Patel (Chairman), Sharvil Patel, various family trusts, HUFs, and related companies, has filed declarations confirming no encumbrances (pledges, liens, or charges) were placed on their equity shares during FY2026 ending March 31, 2026. This is a mandatory year-end compliance filing under SEBI SAST Regulations. All declarations were digitally signed and submitted to BSE and NSE on April 1-2, 2026. Some entities explicitly stated they hold no shares at all, while others confirmed their existing shareholdings remain free of any encumbrances.
Positive signal for shareholders. The absence of encumbrances indicates promoters have not pledged their shares for loans or other obligations, reducing risk of forced sell-offs. This reflects promoter confidence in the company's financial health and their commitment to maintaining control without leveraging shares.